Dr. Laahn Foster, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,796 | 9 | 90.2% |
| Travel and Lodging | $935.00 | 3 | 5.0% |
| Food and Beverage | $862.20 | 14 | 4.6% |
| Education | $20.05 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $7,277 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $5,526 | 4 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $4,115 | 3 | $0 (2024) |
| Janssen Research & Development, LLC | $1,095 | 6 | $0 (2023) |
| Adaptive Biotechnologies Corporation | $201.85 | 2 | $0 (2022) |
| Genmab U.S., Inc. | $157.10 | 1 | $0 (2024) |
| Dr.Reddy's Laboratories,Inc. | $100.00 | 1 | $0 (2018) |
| GENZYME CORPORATION | $92.67 | 1 | $0 (2024) |
| Genentech USA, Inc. | $28.43 | 1 | $0 (2019) |
| PFIZER INC. | $20.05 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,012 | 7 | Janssen Scientific Affairs, LLC ($3,025) |
| 2023 | $6,948 | 10 | E.R. Squibb & Sons, L.L.C. ($4,763) |
| 2022 | $125.43 | 2 | Adaptive Biotechnologies Corporation ($64.30) |
| 2021 | $4,253 | 3 | Janssen Biotech, Inc. ($4,115) |
| 2019 | $28.43 | 1 | Genentech USA, Inc. ($28.43) |
| 2018 | $120.05 | 2 | Dr.Reddy's Laboratories,Inc. ($100.00) |
| 2017 | $127.28 | 2 | E.R. Squibb & Sons, L.L.C. ($127.28) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $157.10 | General |
| Category: Oncology | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| 11/01/2024 | Janssen Biotech, Inc. | TALVEY (Biological) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Janssen Scientific Affairs, LLC | TECVAYLI (Biological) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: Oncology | ||||||
| 04/11/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $92.67 | General |
| Category: Oncology | ||||||
| 03/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,372.00 | General |
| 02/21/2024 | Janssen Scientific Affairs, LLC | TECVAYLI (Biological) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Oncology | ||||||
| 12/11/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $9.93 | General |
| 12/07/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $9.22 | General |
| 08/10/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $4,744.00 | General |
| 05/25/2023 | Janssen Scientific Affairs, LLC | DARZALEX (Biological) | Consulting Fee | Cash or cash equivalent | $1,090.00 | General |
| Category: Oncology | ||||||
| 03/24/2023 | Janssen Research & Development, LLC | CARVYKTI (Drug) | Travel and Lodging | In-kind items and services | $286.75 | General |
| Category: Oncology | ||||||
| 03/24/2023 | Janssen Research & Development, LLC | CARVYKTI (Drug) | Travel and Lodging | In-kind items and services | $220.10 | General |
| Category: Oncology | ||||||
| 03/23/2023 | Janssen Research & Development, LLC | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $97.64 | General |
| Category: Oncology | ||||||
| 03/23/2023 | Janssen Research & Development, LLC | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: Oncology | ||||||
| 03/23/2023 | Janssen Research & Development, LLC | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Oncology | ||||||
| 03/08/2023 | Janssen Research & Development, LLC | CARVYKTI (Drug) | Travel and Lodging | In-kind items and services | $428.15 | General |
| Category: Oncology | ||||||
| 12/10/2022 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | In-kind items and services | $64.30 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 12/09/2022 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $61.13 | General |
| Category: Oncology | ||||||
| 11/17/2021 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | In-kind items and services | $137.55 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 10/19/2021 | Janssen Biotech, Inc. | DARZALEX (Biological) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: Oncology | ||||||
| 07/14/2021 | Janssen Biotech, Inc. | DARZALEX (Biological) | Consulting Fee | Cash or cash equivalent | $1,365.00 | General |
| Category: Oncology | ||||||
| 12/09/2019 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: BioOncology | ||||||
| 08/08/2018 | Dr.Reddy's Laboratories,Inc. | — | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| 05/25/2018 | PFIZER INC. | MYLOTARG (Biological) | Education | In-kind items and services | $20.05 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 444 | 875 | $328,286 | $81,629 |
| 2022 | 8 | 421 | 853 | $280,128 | $74,377 |
| 2021 | 9 | 356 | 685 | $226,779 | $61,926 |
| 2020 | 10 | 351 | 686 | $205,808 | $51,488 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 109 | 352 | $159,847 | $38,464 | 24.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 137 | $40,175 | $12,960 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 91 | 131 | $42,993 | $9,173 | 21.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 43 | 43 | $24,897 | $6,030 | 24.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 69 | $14,007 | $4,339 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 32 | 32 | $14,656 | $3,163 | 21.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 21 | $11,907 | $2,790 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 54 | 60 | $13,698 | $2,781 | 20.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 28 | 30 | $6,106 | $1,928 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 105 | 298 | $120,118 | $32,738 | 27.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 55 | 193 | $56,012 | $15,808 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 88 | 122 | $36,564 | $8,476 | 23.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 101 | $20,350 | $5,764 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 34 | 34 | $19,524 | $4,782 | 24.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $9,575 | $2,694 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 52 | 61 | $12,546 | $2,562 | 20.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 27 | $5,439 | $1,554 | 28.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 83 | 249 | $95,316 | $27,470 | 28.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 40 | 138 | $39,378 | $11,400 | 29.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 85 | 116 | $33,021 | $7,504 | 22.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 34 | 34 | $18,717 | $4,928 | 26.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 55 | $10,875 | $3,162 | 29.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $9,426 | $2,723 | 28.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 22 | 22 | $9,376 | $2,190 | 23.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 39 | 41 | $8,104 | $1,797 | 22.2% |
About Dr. Laahn Foster, M.D
Dr. Laahn Foster, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2011. The National Provider Identifier (NPI) number assigned to this provider is 1699071696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laahn Foster, M.D has received a total of $18,613 in payments from pharmaceutical and medical device companies, with $7,012 received in 2024. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($16,796).
As a Medicare-enrolled provider, Foster has provided services to 1,572 Medicare beneficiaries, totaling 3,099 services with total Medicare billing of $269,420. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Hematology
- Location Charlottesville, VA
- Active Since 02/08/2011
- Last Updated 07/14/2015
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1699071696
Products in Payments
- DARZALEX (Biological) $5,205
- TECVAYLI (Biological) $3,086
- TALVEY (Biological) $1,350
- CARVYKTI (Drug) $1,095
- clonoSEQ (Device) $201.85
- Epkinly (Drug) $157.10
- SARCLISA (Biological) $92.67
- GAZYVA (Biological) $28.43
- MYLOTARG (Biological) $20.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Charlottesville
Hillary Maitland, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $389,378
Brian Wentworth
Student in an Organized Health Care Education/Training Program — Payments: $227,368
Charles Su
Student in an Organized Health Care Education/Training Program — Payments: $41,413
Michael Mccabe, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $23,740
Emily Mcgowan, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $18,445
Xudong Li, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $17,265